Logo image
Characterization of epidermal growth factor receptor mutations in non-small-cell lung cancer patients of African-American ancestry
Journal article   Open access   Peer reviewed

Characterization of epidermal growth factor receptor mutations in non-small-cell lung cancer patients of African-American ancestry

T Harada, A Lopez-Chavez, L Xi, M Raffeld, Y Wang and G Giaccone
Oncogene, v 30(15), pp 1744-1752
14 Apr 2011
PMID: 21132006
url
https://www.ncbi.nlm.nih.gov/pmc/articles/7213757View
Open

Abstract

631/208/737 692/699/67/1059/2326 692/699/67/1612/1350 Apoptosis Article Cell Biology General Human Genetics Internal Medicine Medicine Medicine & Public Health Oncology original-article
Epidermal growth factor receptor (EGFR) mutations are predictive markers for response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer (NSCLC). The most common mutations, exon 19 short deletions and exon 20 point mutation (L858R), activate the tyrosine kinase and confer sensitivity to EGFR-TKIs. However, the function and sensitivity of rare mutations to EGFR-TKIs are unknown. In this study, we found five EGFR mutations out of 16 patients with NSCLC of African-American descent. The frequency of such mutations in this patient population appears to be significantly higher than previously reported. Two of them (N771GY and A767-V769dup) are rare insertion mutations located in exon 20. Using YFP-tagged EGFR mutants, we demonstrated that the mutations confer increased kinase activity, but no sensitivity to erlotinib at clinically available concentrations. In addition, we examined efficacy of PF00299804, an irreversible EGFR-TKI. Although the drug failed to show efficacy to T790M and S768N mutations, the exon 20 insertion mutations were sensitive to PF00299804. These data suggest that rare mutations in exon 20 are resistant to erlotinib but may be sensitive to irreversible inhibitors.

Metrics

7 Record Views
37 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Biochemistry & Molecular Biology
Cell Biology
Genetics & Heredity
Oncology
Logo image